TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/6/21 17:11 | 12/2/21 | CNTA | Centessa Pharmaceuticals Plc | X0 | Health | Drug | Pharmaceutical Preparations | Medicxi Ventures Management (Jersey) Ltd | Y9 | T | P | 440 | 12.82 | 0 | 34 | 0 | 14,187 | I | |||||||||||||||
12/2/21 17:10 | 11/30/21 | CNTA | Centessa Pharmaceuticals Plc | X0 | Health | Drug | Pharmaceutical Preparations | Medicxi Ventures Management (Jersey) Ltd | Y9 | T | P.m | 1,189 | 12.24 | 0 | 97 | 1 | 14,186 | I | |||||||||||||||
11/30/21 17:11 | 11/26/21 | CNTA | Centessa Pharmaceuticals Plc | X0 | Health | Drug | Pharmaceutical Preparations | Medicxi Ventures Management (Jersey) Ltd | Y9 | T | P.m | 797 | 11.64 | 0 | 69 | 0 | 14,184 | I | |||||||||||||||
11/4/21 17:00 | 11/2/21 | AURA | Aura Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Medicxi Ventures Management (Jersey) Ltd | Y9 | T | P.d | 9,940 | 14.00 | 0 | 710 | 71 | I | ||||||||||||||||
6/4/21 16:30 | 6/2/21 | CNTA | Centessa Pharmaceuticals Plc | X0 | Health | Drug | Pharmaceutical Preparations | Medicxi Ventures Management (Jersey) Ltd | Y9 | T | P.d | 12,000 | 20.00 | 0 | 600 | 4 | 14,182 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |